US-Iran war CJP protest in Delhi US-Saudi nuclear deal Wildfires in Europe El Nino

Israel has begun testing a coroanvirus vaccine prototype at a bio-chemical defence laboratory

PM Benjamin Netanyahu said that IIBR has made progress in designing the vaccine and will be starting animal trials.

|Apr 01, 2020, 07:47:37 IST

Israel has begun testing a COVID-19 vaccine prototype on rodents at its bio-chemical defence laboratory, a source said on Tuesday.Prime Minister Benjamin Netanyahu ordered the Israel Institute for Biological Research (IIBR), in rural Ness Ziona, to join the fight against the coronavirus pandemic on 1 February, prompting an easing of its secrecy as it cooperates with civilian scientists and private firms.In a statement, Netanyahu’s office said IIBR director Shmuel Shapira had informed him of “significant progress” in designing a vaccine prototype and that the institute “is now preparing a model for commencing an animal trial”.[caption id="attachment_7424821" align="alignnone" width="1280"] The trial for the HIV vaccine — known as HVTN 702 but nicknamed Uhambo, means “journey” in Zulu — included 5,407 young adult men and women in South Africa. Image credit: Billion Photos/ Shutterstock

The trial for the HIV vaccine — known as HVTN 702 but nicknamed Uhambo, means “journey” in Zulu — included 5,407 young adult men and women in South Africa. Image credit: Billion Photos/ Shutterstock

Israel is testing a coronavirus prototype vaccine on rodents. Image credit: Billion Photos/ Shutterstock[/caption]A source familiar with IIBR activities told Reuters that trials were already underway on rodents. The source declined to identify the kind of rodent.The IIBR is widely assumed to have worked on biological and chemical arms projects. Israel neither confirms nor denies this.In rare public comments, IIBR chief innovation officer Eran Zahavy said last week that the institute had shifted its entire focus to the new coronavirus, with three groups trying to develop a vaccine against the COVID-19 disease it causes, and others researching potential treatments.“We are trying as much as we can to collaborate and have other ideas of other people,” he said at last week’s English-language online conference hosted by Jerusalem Venture Partners.“But the facility of the lab is very crowded and very busy and very dangerous so it has to be very slow and very cautious.”Israel has reported 4,473 cases of COVID-19 and 17 fatalities. Having tightened restrictions on public movement, Netanyahu is weighing a lockdown of parts of the country.Both Netanyahu and the chief of Israel’s military, Lieutenant-General Aviv Kohavi, went into self-isolation this week after being exposed to coronavirus carriers. Netanyahu tested negative for the virus on Monday. Test results for Kohavi are pending, the military said.Zahavy described arranging an animal test-subject as “a very big challenge” because “this disease is not affecting animals”.“It’s not enough only to detect neutralizing antibodies in the animal. You really want to see them getting sick and getting better by this vaccine,” he said.The IIBR has a “unique animal” for such tests, he said, as well as “a very unique technology to detect animals - even if they are not really sick - to follow them and see their interaction with the disease”. He did not elaborate.The IIBR is also involved in plasma collection from people who have recovered from infection with the new coronavirus, in the hope that this might help research.Israeli Defense Minister Naftali Bennett said the IIBR was sampling several COVID-19 testing kits on offer before the country orders them en masse.

Stroke is rising among young adults. Doctor explains why it's happening and what you must do

Stroke is increasingly affecting adults in their 30s, 40s and 50s. Experts say unhealthy lifestyles, undiagnosed high blood pressure and delayed treatment are driving the rise in younger stroke cases

3 min read

Stroke in young adults, silent symptoms and late diagnosis: India's growing brain health challenge

Neurologists warn that stroke is increasingly affecting people in their 30s and 40s, while many brain disorders progress silently before symptoms appear. They say early diagnosis, timely referrals and healthier lifestyles are key to reducing India's growing neurological disease burden.

5 min read

Brain tumours aren't always fatal, but delayed diagnosis can be: Experts explain the key warning signs

Brain tumours are frequently mistaken for common headaches, stress or age-related cognitive changes. Doctors say recognising warning signs early and adopting a brain-healthy lifestyle can improve outcomes and reduce the risk of long-term neurological complications.

2 min read

Spices, health and the Indian plate: Why chilli can be good for you—but moderation is still key

From boosting metabolism to supporting heart health, chillies offer several surprising health benefits. But experts say the amount you eat matters, and too much spice can do more harm than good.

4 min read

Organ donation: 5 myths you need to stop believing, according to a transplant specialist

Organ donation has the power to transform and save lives, but this can happen only when myths are replaced with facts. Building awareness, having open conversations and understanding the process can help families make informed decisions.